[1]Felderbauer P, Müller C, Bulut K, et al.Pathophysiology andtreatment of acute pancreatitis:new therapeutic targets-a ray ofhope?[J].Basic Clin Pharmacol Toxicol, 2005, 97 (6) ∶342-350.
|
[2]Bhatia M, Wong FL, Cao Y, et al.Pathophysiology of acute pan-creatitis.[J].Pancreatology 2005, 5 (2-3) ∶132-144.
|
[3]Breckwoldt MO, Chen JW, Stangenberg L, et al.Tracking the in-flammatory response in stroke in vivo by sensing the enzyme my-eloperoxidase.[J].Proc Natl Acad Sci USA, 2008, 105 (47) ∶18584-18589.
|
[4]El Kebir D, József L, Pan W, et al.Myeloperoxidase delays neu-trophil apoptosis through CD11b/CD18 integrins and prolongs in-flammation.[J].Circ Res, 2008, 103 (4) ∶352-359.
|
[5]Bhatia M, Hegde A.Treatment with anti-leukinate, a CXCR2chemokine receptor antagonist, protects mice against acute pancre-atitis and associated lung injury.[J].Regul Pept, 2007, 138 (1) ∶40-48.
|
[6]Gül M, Erefoglu M, ztürk F, et al.The beneficial effects of pen-toxifylline on caerulein-induced acute pancreatitis in rats[J].DigDis Sci, 2009, 54 (3) ∶555-563.
|
[7]中华医学会消化病学分会胰腺疾病学组.中国急性胰腺炎诊治指南 (草案) [J].中华消化杂志, 2004, 24 (3) ∶190-192.
|
[8]Yao V, McCauley R, Cooper D, et al.Myeloperoxidase response toperitonitis in an experimental model[J].ANZ J Surg, 2003, 73 (12) ∶1052-1056.
|
[9]De Campos T, Deree J, Martins JO, et al.Pentoxifylline attenuatespulmonary inflammation and neutrophil activation in experimentalacute pancreatitis[J].Pancreas, 2008, 37 (1) ∶42-49.
|
[10]Zhu DJ, Xia B, Bi Q.Functional protection of pentoxifylline a-gainst spinal cord ischemia/reperfusion injury in rabbits:necrosisand apoptosis effects[J].Chin Med (Engl) , 2008, 121 (23) ∶2444-2449.
|